1. Functional evaluation of five BRCA2 unclassified variants identified in a Sri Lankan cohort with inherited cancer syndromes using a mouse embryonic stem cell-based assay
    Nirmala Sirisena et al, 2020, Breast Cancer Research CrossRef
  2. Contribution of BRCA1 and BRCA2 germline mutations to early onset breast cancer: a series from north of Morocco
    Joaira Bakkach et al, 2020, BMC Cancer CrossRef
  3. BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer
    F. Z. Francies et al, 2015, BMC Cancer CrossRef
  4. First description of a double heterozygosity for BRCA1 and BRCA2 pathogenic variants in a French metastatic breast cancer patient: A case report
    Guillaume Meynard et al, 2017, Oncology Reports CrossRef
  5. Frequency of Pathogenic Germline Mutations in Early and Late Onset Familial Breast Cancer Patients Using Multi-Gene Panel Sequencing: An Egyptian Study
    Auhood Nassar et al, 2022, Genes CrossRef
  6. A Comprehensive Focus on Global Spectrum ofBRCA1andBRCA2Mutations in Breast Cancer
    Fatemeh Karami et al, 2013, BioMed Research International CrossRef
  7. Mutational profile of hereditary breast and ovarian cancer – Establishing genetic testing guidelines in a developing country
    Ana Krivokuca et al, 2022, Current Problems in Cancer CrossRef
  8. BRCA gene mutations: A population based review
    Ratika Samtani et al, 2019, Gene Reports CrossRef
  9. Aggregate penetrance of genomic variants for actionable disorders in European and African Americans
    Pradeep Natarajan et al, 2016, Science Translational Medicine CrossRef
  10. Genetic testing results in Slovenian male breast cancer cohort indicate the BRCA2 7806-2A > G founder variant could be associated with higher male breast cancer risk
    Ksenija Strojnik et al, 2021, Breast Cancer Research and Treatment CrossRef
  11. Genetic counselling, BRCA1/2 status and clinico-pathologic characteristics of patients with ovarian cancer before 50 years of age
    Mirjam Cvelbar et al, 2017, Radiology and Oncology CrossRef
  12. Novel BRCA1 splice-site mutation in ovarian cancer patients of Slavic origin
    Ana Krivokuca et al, 2018, Familial Cancer CrossRef
  13. Characterization of medulloblastoma in Fanconi Anemia: a novel mutation in the BRCA2 gene and SHH molecular subgroup
    Evelina Miele et al, 2015, Biomarker Research CrossRef
  14. The first case report of a large deletion of the BRCA1 gene in Croatia
    Vesna Musani et al, 2017, Medicine CrossRef
  15. Bilateral Disease Common Among Slovenian CHEK2-Positive Breast Cancer Patients
    Tea Nizic-Kos et al, 2021, Annals of Surgical Oncology CrossRef
  16. Functional Analysis of BARD1 Missense Variants in Homology-Directed Repair of DNA Double Strand Breaks
    Cindy Lee et al, 2015, Human Mutation CrossRef
  17. Germline mutations in cancer susceptibility genes in high grade serous ovarian cancer in Serbia
    Ana Krivokuca et al, 2019, Journal of Human Genetics CrossRef
  18. The contribution of large genomic rearrangements in BRCA1 and BRCA2 to South African familial breast cancer
    Nerina C. van der Merwe et al, 2020, BMC Cancer CrossRef
  19. Genetic testing and counseling of a recipient after bone marrow transplant from a sibling harboring a germline BRCA1 pathogenic mutation
    Petra Škerl et al, 2017, Oncology Reports CrossRef